• Home
  • Articles
  • COVID-19
  • News
    • Biotech News – Featured
    • Biotech News
    • BioGadgets
  • Interviews
    • Interviews – Academia
    • Interviews – Industry
  • Issues
  • Subscribe
  • Board
  • Advertise
Facebook Twitter Instagram
Trending
  • BioAsia 2023 to be held in February 24-26 in Telangana, India
  • Praj Industries and ESIIC partner to further bioeconomy in Egypt
  • Who is The Real Anthony Fauci? A true Doctor, liar, pharma profiteer or a totalitarian?
  • Guestorial: MALNUTRITION ACCELERATES THE METABOLIC AGE
  • Event: Australia’s biggest week in biotech kicks off in Perth
  • $3 trillion growth reported for biotech sector in USA
  • Event : FABA’s Whale Tank Event – “Venture Capital – Biotech Start-up Connect”
  • Vaccination, Rising Deaths, And The False Narrative
Biotech Express Magazine
  • Home
  • Articles
  • COVID-19
  • News
    • Biotech News – Featured
    • Biotech News
    • BioGadgets
  • Interviews
    1. Interviews – Academia
    2. Interviews – Industry
    Featured
    January 16, 20211

    Interview – Prof Rajeev K Varshney “The Youngest Indian Scientist (47)” who achieved an h-index of 100 recently

    Recent
    July 26, 2022

    We are making best hygiene solutions through Biotech applications: Dr Rachna Dave, founder MicroGO

    March 30, 2022

    Interview- Bioenergy: India’s Ministry of New and Renewable Energy started almost four decades ago…but did not catch up…, Professor Ashok Pandey

    January 24, 2022

    Interview: Prof Kailash Chander Bansal, Secretary, National Academy of Agricultural Sciences (NAAS), India

  • Issues
  • Subscribe
  • Board
  • Advertise
Biotech Express Magazine
You are at:Home»Biotech News»Mahima Datla and BP Acharya to receive FABA 2022 special awards

Mahima Datla and BP Acharya to receive FABA 2022 special awards

0
By Biotech Express on February 22, 2022 Biotech News

Mahima Datla, managing director of Biological E Limited from Hyderabad and B P Acharya, patron of Federation of Asian Biotech Association (FABA) have been conferred with Dr B S Bajaj Memorial FABA Special Award-2022 and FABA Lifetime Achievement Award, respectively for their immense contribution to the biotechnology sector in India. The FABA special awards will be conferred during the 19th edition of BioAsia, the largest annual global biotechnology and life sciences summit of Asia, organised by the Government of Telangana and FABA.

The 44-year-old Mahima has a Bachelor’s Degree in Business Administration Management from Webster University, London, has been with Biological E since 2001. Founded in 1948 by her grandfathers as Biological Products Pvt Ltd, the company started out by manufacturing Heparin, a drug to prevent blood clots.

Mahima Datla is named for the FABA award for introducing Corbevax vaccine, which is regarded as India’s indigenously developed Covid-19 vaccine. Corbevax is a protein subunit COVID-19 vaccine developed by Texas Children’s Hospital Center for Vaccine Development and Baylor College of Medicine in Houston, Texas and Dynavax technologies based in Emeryville California. It is licensed to Indian biopharmaceutical firm Biological E. Limited (BioE) for development and production.

According to experts, Corbevax is a recombinant vaccine, developed from the receptor binding domain (RBD) of the spike protein on the virus’s surface combined with Dynavax’s CpG 1018 adjuvant with alum, which helps the body build the immune response against the virus. The protein is produced by the yeast Pichia pastoris; the process is similar to that of existing Hepatitis B vaccines.

Prof. Reddanna, executive president, FABA while speaking at the announcement of the awards, said, “The Dr B S Bajaj Memorial Award is a distinction bestowed on the individual or organization most committed to the advancement of Life Sciences. The contributions made by Biological E under the abled leadership of Mahima Datla are conscientiously recognized and commended by the biotechnology fraternity. Their vaccine, Corbevax being scalable and affordable to the low-middle income countries, makes Biological E the most promising candidate for this award”.

B. P. Acharya (born 30 October 1960) is a senior officer of the 1983 batch Indian Administrative Service (IAS). On his retirement in 2020, he was Director General for MCR HRD Institute of Telangana and also Special Chief Secretary in General Administration Department for Telangana State.

The Indian Council of Medical Research (ICMR) in 2021 has appointed retired Telangana bureaucrat BP Acharya, as the advisor of the National Animal Resource Facility for Bio Medical Research (NARFBR) that is coming up over an area of 100 acres at the Genome valley near Shamirpet.

Acharya had served as the Special Chief Secretary in before retirement and also as the DG of MCRHRD Institute of Telangana. The ICMR said that this appointment is in recognition of Acharya’s efforts to create the world-class life sciences cluster in the Genome Valley and his contribution to the sector. The NARFBR project is being developed with an investment of Rs 300 crore and will cater to the pharma and biopharma/vaccine industry in the country in their pre-clinical animal trials.

As Secretary, Industries and Commerce, he was involved in creating Genome Valley on the outskirts of Hyderabad and many such industrial clusters.[6] After retirement, he was appointed as advisor to the Indian Council of Medical Research for their National Animal Resource Facility for Biomedical Research in Genome Valley.

Adding further Reddanna also hailed the services rendered by B P Acharya, who has been conferred with FABA Lifetime Achievement Award and said that Acharya has been serving as advisor to ICMR for the National Animal Resource Facility for Biomedical Research (NARFBR) ever since the time of his retirement from MHRD in 2020 and his coordinating efforts and initiatives taken up by him during the regime of government of Andhra Pradesh are commendable as it has helped develop the concrete base for the Genome Valley and Biotech Sector in Hyderabad.

It is also learnt that B P Acharya’s efforts have enabled the erstwhile Andhra Pradesh state achieve the ‘Bio State of the Year 2003’ Award, 19 years ago and from then onwards the Biotechnology sector in Hyderabad has grown to become the global vaccine manufacturing hub in India.

About FABA
Federation of Asian Biotech Associations (FABA), established in 2005, is a non-profit organization created to provide a global platform for the development of biotechnology across the globe, particularly in Asian countries.

The mission of FABA is to promote innovation and entrepreneurship in the biotech industry, academia, and healthcare sector. For more than 15 years, FABA has been fostering collaboration between academia, industry, and government, thus promoting investments in biotechnology and related fields. FABA promotes collaboration between academia and industries engaged in Biotechnology among the member countries in Asia.

Know more: https://biofaba.org.in

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
Biotech Express
  • Website
  • Facebook
  • Twitter
  • LinkedIn

ISSN: 2454-6968 | Biotech Express Magazine publishes articles in the field of biotechnology and allied sciences in a way that have never been presented earlier. It publishes Editorials, Guest Articles, Reports, Interviews, Current News of Govt. Academics and Business, Research Highlights and Notifications of Events, Jobs, Research Proposals in the field of Biotechnology, Biological Sciences, Life Sciences, Microbiology, Biochemistry, Neurosciences, Genetics, Medical Sciences, BioPharma etc.

Related Posts

Praj Industries and ESIIC partner to further bioeconomy in Egypt

$3 trillion growth reported for biotech sector in USA

Bombay HC Issues Notice To Bill Gates, Serum Institute, DGCI, Others Over Plea On Alleged ‘Vaccine Death’

Leave A Reply Cancel Reply

Current Issue – October 2022
Upcoming Event

                   VIEW SUBSCRIPTION PLANS

JOBS/NOTIFICATIONS

   

         CLICK HERE FOR RECENT NOTICES

Recent Posts
  • BioAsia 2023 to be held in February 24-26 in Telangana, India January 10, 2023
  • Praj Industries and ESIIC partner to further bioeconomy in Egypt November 10, 2022
  • Who is The Real Anthony Fauci? A true Doctor, liar, pharma profiteer or a totalitarian? November 1, 2022
  • Guestorial: MALNUTRITION ACCELERATES THE METABOLIC AGE October 31, 2022
  • Event: Australia’s biggest week in biotech kicks off in Perth October 26, 2022
  • $3 trillion growth reported for biotech sector in USA October 25, 2022
  • Event : FABA’s Whale Tank Event – “Venture Capital – Biotech Start-up Connect” September 21, 2022
  • Vaccination, Rising Deaths, And The False Narrative September 20, 2022
  • Guestorial: Genome Mapping Techniques and its Application in Aquaculture September 19, 2022
  • Bombay HC Issues Notice To Bill Gates, Serum Institute, DGCI, Others Over Plea On Alleged ‘Vaccine Death’ September 5, 2022
  • Deaths due Covid-19 vaccines should be compensated by vaccine makers: Expert hope on Kerala HC remark August 21, 2022
  • Maker of Dolo-650, pandemic’s ‘magic pill’, faces income tax searches and PIL petitions August 20, 2022
  • Anthony Fauci, Controversial US Top-doc FINALLY, To Retire By Year-end August 20, 2022
  • SII’s Cervevac: The new DCGI approved vaccine without published clinical trial results August 20, 2022
  • Pitch your Start-up to National/International Venture Capitalists – first ever opportunity provided to Bio-Start-ups by FABA August 19, 2022
  • India’s Clinical Trial Registry might disappear soon and so the history of pharma record August 19, 2022
  • Nearly Half of Pregnant Women in Pfizer Trial Miscarried August 10, 2022
  • Researchers develop Cellulose shoes made by bacteria August 9, 2022
  • Biocon Sdn. Bhd. Enters Malaysia Book of Records as the First & the Largest Integrated Insulin Manufacturing Facility August 5, 2022
  • CBI Arrests of CDSCO officials, a Biocon official & Intermediaries in an alleged bribery case exposed Corruption in Govt and Pharma sector July 27, 2022
  • We are making best hygiene solutions through Biotech applications: Dr Rachna Dave, founder MicroGO July 26, 2022
  • EVENT HIGHLIGHTS: Genome editing as a novel technology for sustainable development July 24, 2022
  • US Military Doctor Testifies under Oath That She Was ORDERED To ‘Cover up’ COVID Vaccine Injuries July 24, 2022
  • Climatic Effect on Marine Biodiversity and their impact on coral reefs July 23, 2022
  • Highlights of India’s first Biotech startup Expo June 13, 2022
  • NTU Singapore scientists develop a ‘fabric’ that turns body movement into electricity June 6, 2022
  • Researchers who jumped into the field from distant disciplines published lower impact work, study finds May 30, 2022
  • Amrita Vishwa Vidyapeetham gets CDSCO nod for clinical trials of first-of-its-kind synthetic jaw-bone graft May 26, 2022
  • AstraZeneca Covid-19 vaccines which uses a chimpanzee adenovirus inked to monkeypox outbreak May 25, 2022
  • Concerns Mount Over COVID-19 ‘Rebounds’ After Treatment With Pfizer’s Paxlovid May 25, 2022
Archives
Categories
  • Articles
  • Articles- Editorials
  • Articles- Guestorials
  • BioControversial
  • BioEvents
  • BioGadgets
  • BioPolicies
  • BioResearch – Academic
  • Biotech News
  • Biotech News – Featured
  • Contents
  • Interviews
  • Interviews – Academia
  • Interviews – Industry
  • SARS- CoV2 & COVID-19 Updates
  • startups
About Us

Biotech Express Magazine publishes articles in the field of biotechnology and allied sciences in a way that have never been presented earlier. It publishes Editorials, Guest Articles, Reports,  Interviews, Current News of Govt. Academics and Business, Research Highlights and Notifications of Events, Jobs, Research Proposals in the field of Biotechnology and allied sciences like Biological Sciences, Life Sciences, Microbiology, Biochemistry, Neurology, Genetics, Medical Sciences, BioPharma etc.

Call us: _91-9311986177

Email – biotechexpressindia@gmail.com

About Us

About Biotech Express

Advisory and Editorial Board

Contact Us

Policy and Guidelines

Submission policies

Peer review policy    

Copyright policy

 

Follow Us
  • Facebook
  • Twitter
We use cookies to help provide and enhance our service and tailor content and ads. By continuing you agree to the use of cookies. Copyright © 2013-2020 Biotech Express except certain content provided by third parties.

Type above and press Enter to search. Press Esc to cancel.